Page last updated: 2024-08-26

1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and deferoxamine

1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one has been researched along with deferoxamine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dobbin, PS; Hall, AD; Hider, RC; Porter, JB; Sarpong, P; Taylor, PD; van der Helm, D; Xiao, G1
Dickey, KM; Fredenburg, AM; Hong, CB; Meurer, KA; Skinner, TL; Yokel, RA1
Garbowski, M; Porter, J; Vlachodimitropoulou Koumoutsea, E1
Chen, YL; Cooper, N; Garbowski, M; Hider, R; Koonyosying, P; Porter, J; Psaila, B; Sola-Visner, M; Vlachodimitropoulou, E1

Other Studies

4 other study(ies) available for 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and deferoxamine

ArticleYear
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
    Journal of medicinal chemistry, 1993, Aug-20, Volume: 36, Issue:17

    Topics: Administration, Oral; Animals; Crystallography; Deferoxamine; Horses; Humans; Iron; Iron Chelating Agents; Liver; Mice; Pyridones; Rats; Stereoisomerism; Structure-Activity Relationship

1993
Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicity.
    Drug metabolism and disposition: the biological fate of chemicals, 1997, Volume: 25, Issue:2

    Topics: Administration, Oral; Aluminum Compounds; Anemia; Animals; Bile; Chelating Agents; Deferoxamine; Kidney Diseases; Lactates; Male; Osteomalacia; Pyridines; Pyridones; Rabbits; Tissue Distribution

1997
Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization.
    British journal of haematology, 2015, Volume: 170, Issue:6

    Topics: Benzoates; Cell Line; Deferasirox; Deferiprone; Deferoxamine; Drug Synergism; Humans; Intracellular Space; Iron; Iron Chelating Agents; Pyridones; Triazoles

2015
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.
    Blood, 2017, 10-26, Volume: 130, Issue:17

    Topics: Animals; Benzoates; Cell Line, Tumor; Deferoxamine; Extracellular Space; Ferritins; Hepatocytes; Humans; Hydrazines; Insulin; Insulin Secretion; Insulin-Secreting Cells; Iron; Iron Chelating Agents; Myocytes, Cardiac; Pyrazoles; Pyridones; Rats; Reactive Oxygen Species

2017
chemdatabank.com